Human stories do not soften science.
They reveal why it matters.

As a University of Exeter alumna, I went with particular interest to a recent event at The Academy of Medical Sciences, where four of the university’s leading scientists explored how genomics is changing the future of medicine.

Across rare disease, diabetes, women’s health and dementia, the scientific progress was extraordinary. But its power did not come from being told simply “look what the science can do”. It came from seeing what changes when that science reaches the person who needs it.

A critically ill baby waiting for answers. A child whose diagnosis changed the course of treatment. A person with diabetes whose genetic profile meant the standard label did not tell the full story. Women trying to understand fertility, menopause and long-term health. Families facing dementia long after the earliest biological changes may already have begun.

There is a lesson there for anyone trying to communicate complex ideas.

We often talk about making science simpler. There is some truth in that, of course. Nobody outside a specialist audience wants to be buried under terminology. But the Exeter event showed something more interesting. The speakers did not dumb down the science, they made it consequential.

Rapid genome sequencing became understandable when it was attached to a baby in intensive care, where time was not an abstract measure of innovation but the difference between uncertainty and a treatment plan. Precision diabetes became meaningful when it showed why one person’s diagnosis could point to a different therapy. Research into reproductive ageing became more than a scientific field when it touched decisions about fertility, menopause and women’s long-term health. Dementia research became sharper when framed around the need to understand what is happening in the brain years before symptoms appear.

For organisations working in difficult, technical or still-emerging areas, there is often a temptation to lead with proof. The data. The breakthrough. The funding. The scale of the problem. All of that has its place, especially in health, where credibility matters deeply.

But proof alone rarely creates meaning. People need to understand what the evidence changes. What decision becomes possible? What delay is shortened? What uncertainty is reduced? What future becomes easier to imagine?

This is not about using human stories as decoration. In the best health communications, the human story is not the soft bit after the science. It is where the impact becomes visible.

That matters even more as medicine becomes more precise. Genomics, AI-enabled diagnostics, personalised treatments and predictive tools all promise to move healthcare away from broad categories and towards more individual answers. Yet the more precise the science becomes, the more carefully it needs to be explained. Personalisation can inspire hope, but it can also raise questions about trust, consent, access, anxiety and fairness.

Much of the communications challenge sits there: between what the science can do and what people are ready to understand, believe and act on.

The future of medicine may be shaped by genetic code, datasets and molecular insight. But most people will understand it through moments that feel much closer to home: a parent getting an answer, a clinician choosing a better treatment, a woman making a more informed decision or a family seeing the possibility of earlier action.

Scientific progress can be extraordinary and still struggle to connect unless people can see what changes in a real life.

That is the lesson I took from the evening. Start with the science, and people may be impressed. Show what it changes for someone, and they are more likely to understand why it matters.